Yohei Hisada, PhD

Assistant Professor
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States

Yohei Hisada earned his Ph.D. in the University of Tokyo in 2014. During his graduate studies, he developed a new method for cancer therapy/diagnosis by targeting fibrin in cancer tissue using a monoclonal antibody produced in Dr. Yasuhiro Matsumura’s laboratory. In 2014, he joined Dr. Nigel Mackman’s laboratory in the University of North Carolina at Chapel Hill as a postdoc. Currently, as a research assistant professor, he is studying the mechanisms of cancer-associated venous thrombosis and bleeding using mouse models and human samples.

Presentation(s):

• SSC 17.7 - Summary of the problematic TF measurements using cutting-edge technologies

  Monday, June 26, 2023
  17:00 – 17:15 ET

• PB0712 - Establishment of mouse xenograft and allograft models of acute promyelocytic leukemia and role of tissue factor in the activation of coagulation

  Monday, June 26, 2023
  18:30 – 19:30 ET

• OC 64.3 - Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia

  Tuesday, June 27, 2023
  15:15 – 15:30 ET

• PB1070 - Small and large extracellular vesicles have different tissue factor activity in cancer, sepsis, and COVID-19

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1102 - Evaluation of the ability of commercial ELISAs to measure tissue factor in human plasma

  Tuesday, June 27, 2023
  18:30 – 19:30 ET